FindTrial
Sign In

The effect of prenatal esketamine exposure on offspring development: a retrospective cohort study

The effect of prenatal esketamine exposure on offspring development: a retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090420
Enrollment
Unknown
Registered
2024-09-29
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism

Interventions

S-ketamine assisted epidural analgesia group:NA
Control group:NA

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.5 Years to 3 Years

Inclusion criteria

Inclusion criteria: The maternal were: 18 years old or above, full-term single pregnancy, regular prenatal examination, epidural anesthesia and cesarean section.

Exclusion criteria

Exclusion criteria: Preterm infants (i.e., <36 weeks gestation at the time of delivery); Low birth weight (i.e. birth weight <2500 g); Severe birth asphyxia or birth injury (diagnosed by a doctor) at birth; Children with disabilities; One or both parents have an intellectual or mental abnormality; Children who have a sibling already selected.

Design outcomes

Primary

MeasureTime frame
Modified Autism Scale for Infants;—

Countries

China

Contacts

Public ContactHeliang Sun

The First Affiliated Hospital of Nanjing Medical University

njmu528@163.com+86 25 8621 5953

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026